Psychedelics Funding At Its Best: $1.5M Destined To Psilocin Clinical Trials In Australia
Psychedelics biopharma company Lobe Sciences Ltd.
Lobe Sciences Signs Exclusive Deal For Psilocin Clinical Trials In Australia
Life sciences company Lobe Sciences Ltd.
Two Psychedelic Companies File Patent Applications For Psilocybin And MDMA Analogues, Here’s What Could Change
Mydecine (OTC: MYCOF) and Lobe Sciences (OTCQB: LOBEF), two companies in the psychedelics space, have filed patent applications.